Primrose Bio
Americas
San Diego
,
United States
Established
FOUNDED
2023
HEADCOUNT
21-100
FUNDING
Growth / PE-backed
Keywords:
fermentation, precision_fermentation, bacteria, therapeutics, vaccines, CDMO, enzymes
BUSINESS
Primrose Bio is a protein expression and enzyme engineering company formed through the merger of Pelican Technology Holdings (formerly Pfenex, a Ligand Pharmaceuticals subsidiary) and Primordial Genetics. The company holds more than 200 patents globally and operates two core platforms: Pelican Expression Technology, a Pseudomonas fluorescens-based recombinant protein production system used in six approved products, and Function Generator, an ultra-high-throughput novel gene generation system for enzyme and microbe discovery.
BIOTECH INVOLVEMENT
Recombinant protein expression and enzyme engineering are the entire basis of the business, anchored on a P. fluorescens microbial host platform for therapeutic and vaccine protein manufacturing. The Function Generator platform supports gene library generation and enzyme discovery, and the Prima RNApols product line targets the mRNA manufacturing supply chain.
TECHNOLOGY PLATFORM
Pfenex Expression Technology (Pseudomonas fluorescens); Prima RNApols
PRIMARY PRODUCTS
Pfenex platform for antibody derivatives and vaccine antigens; Prima RNApols for mRNA; PeliCRM197 carrier protein